FUNCTIONAL ASSESSMENT OF PATIENTS WITH NODULAR FORMATIONS OF THE THYROID GLAND
Keywords:
thyroid gland, nodules, formationsAbstract
Thyroid nodules are often detected by ultrasound of the neck. Most nodules are benign; therefore, many nodes are biopsied to identify the small number of nodes that are malignant or require surgery for definitive diagnosis.
Methodology for revealing the research problem. 157 patients with thyroid nodules were examined. Of the 157 patients, there were 91 men, 66 women. The patients were divided into 4 groups:
Research results. The analysis showed that hypothyroidism was observed in 57 (36.3%) patients, hyperthyroidism – in 51 (33.5%) and euthyroidism – in 49 (31.2%) patients.
References
Dean DS, Gharib H. Epidemiology of thyroid nodules. //Best Pract Res Clin Endocrinol Metab. 2008;22(6):901‐911.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. //Thyroid. 2016;26(1):1‐133.
Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow‐up in 236 patients. // Eur Radiol. 2008;18(6):1244‐1250.
Watt T Cramon P Hegedüs L Bjorner JB Bonnema SJ Rasmussen ÅK Feldt-Rasmussen U & Groenvold M. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. // Journal of Clinical Endocrinology and Metabolism 2014993708–3717. (10.1210/jc.2014-1322).
Watt T, Barbesino G, Bjorner JB, Bonnema SJ, Bukvic B, Drummond R, Groenvold M, Hegedüs L, Kantzer V, Lasch KE, et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. //Quality of Life Research 201524769–780. (10.1007/s11136-014-0798-1).
Nordqvist SF Boesen VB Rasmussen ÅK Feldt-Rasmussen U Hegedüs L Bonnema SJ Cramon PK Watt T Groenvold M & Bjorner JB. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO. //Endocrine Connections 202110316–324. (10.1530/EC-21-0026.
Hegedüs L. Clinical practice. The thyroid nodule. //New England Journal of Medicine 20043511764–1771. (10.1056/NEJMcp031436).
Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. // Journal of Clinical Endocrinology and Metabolism 200489163–168. (10.1210/jc.2003-030550).
Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. //Journal of Clinical Endocrinology and Metabolism 200792450–455. ( 10.1210/jc.2006-1590)
Costante G Durante C Francis Z Schlumberger M & Filetti S. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. //Nature Clinical Practice. Endocrinology and Metabolism 2009535–44. ( 10.1038/ncpendmet1023)
Chambon G Alovisetti C Idoux-Louche C Reynaud C Rodier M Guedj AM Chapuis H Lallemant JG & Lallemant B. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. //Journal of Clinical Endocrinology and Metabolism 20119675–81. (10.1210/jc.2010-0162)
Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega S, Sadeghi R, Crescenzi A, Faquin WC, Bongiovanni M, et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. //Clinical Endocrinology 201582280–285. (10.1111/cen.12563)
Fugazzola L, Di Stefano M, Censi S, Repaci A, Colombo C, Grimaldi F, Magri F, Pagotto U, Iacobone M, Persani L, et al. Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment. //Journal of Endocrinological Investigation 202144587–597. (10.1007/s40618-020-01356-9)
Pires AT, Mustafá AMM, Magalhães MOG. The 2017 ACR TI-RADS: pictorial essay. //Radiol Bras. 2022 Jan-Feb;55(1):47-53. doi: 10.1590/0100-3984.2020.0141.
Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Hammers LW, Hamper UM, Langer JE, Reading CC, Scoutt LM, Stavros AT. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. //J Am Coll Radiol. 2017 May; 14(5):587-595. doi: 10.1016/j.jacr.2017.01.046.
